These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15237387)

  • 81. Antagonist-radioligand binding to D2L-receptors in intact cells.
    Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
    Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis and evaluation of fluorine-substituted 1H-pyrrolo[2,3-b]pyridine derivatives for dopamine D4 receptor imaging.
    Oh SJ; Lee KC; Lee SY; Ryu EK; Saji H; Choe YS; Chi DY; Kim SE; Lee J; Kim BT
    Bioorg Med Chem; 2004 Nov; 12(21):5505-13. PubMed ID: 15465327
    [TBL] [Abstract][Full Text] [Related]  

  • 83. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Spectroscopic investigation of the interaction between diperoxovanadate complexes and benzimidazole-like ligands.
    Yu X; Yang F; Ji D; Zhou J; Liu R; Li G; Li X; Chen J; Huang H; Yi P
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Nov; 77(4):816-20. PubMed ID: 20801712
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
    Thobois S; Vingerhoets F; Fraix V; Xie-Brustolin J; Mollion H; Costes N; Mertens P; Benabid AL; Pollak P; Broussolle E
    Arch Neurol; 2004 Nov; 61(11):1705-9. PubMed ID: 15534182
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
    Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H
    Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Distribution of D1-like and D2-like dopamine receptors in the brain of genetic epileptic WAG/Rij rats.
    Birioukova LM; Midzyanovskaya IS; Lensu S; Tuomisto L; van Luijtelaar G
    Epilepsy Res; 2005 Feb; 63(2-3):89-96. PubMed ID: 15715998
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis of hexahydrocyclopenta[ij]isoquinolines as a new class of dopaminergic agents.
    Párraga J; Galán A; Sanz MJ; Cabedo N; Cortes D
    Eur J Med Chem; 2015 Jan; 90():101-6. PubMed ID: 25461315
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles.
    Schlotter K; Boeckler F; Hübner H; Gmeiner P
    J Med Chem; 2005 Jun; 48(11):3696-9. PubMed ID: 15916420
    [TBL] [Abstract][Full Text] [Related]  

  • 93. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
    Lane JR; Powney B; Wise A; Rees S; Milligan G
    J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dopamine/serotonin receptor ligands. Part 17: a cross-target SAR approach: affinities of azecine-styled ligands for 5-HT(2A) versus D1 and D2 receptors.
    Enzensperger C; Görnemann T; Pertz HH; Lehmann J
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3809-13. PubMed ID: 18534847
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts.
    Nencini C; Cavallo F; Capasso A; De Feo V; De Martino L; Bruni G; Giorgi G; Micheli L
    J Ethnopharmacol; 2006 Nov; 108(2):185-7. PubMed ID: 16839726
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction.
    Cowart M; Latshaw SP; Bhatia P; Daanen JF; Rohde J; Nelson SL; Patel M; Kolasa T; Nakane M; Uchic ME; Miller LN; Terranova MA; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino BR; Lynch JJ; Sullivan JP; Hsieh GC; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2004 Jul; 47(15):3853-64. PubMed ID: 15239663
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the affinity for D2L, D4.2, and 5-HT2A receptors.
    Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1570-4. PubMed ID: 17251022
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubility.
    Chen J; Ding K; Levant B; Wang S
    Bioorg Med Chem Lett; 2006 Jan; 16(2):443-6. PubMed ID: 16290142
    [TBL] [Abstract][Full Text] [Related]  

  • 100. N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.
    Herm L; Berényi S; Vonk A; Rinken A; Sipos A
    Bioorg Med Chem; 2009 Jul; 17(13):4756-62. PubMed ID: 19454369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.